Purchases and Sales Made in Q2 2023 in Hillstream Bio Pharma Inc. (HILS)
This table provides information about the institutional ownership of Hillstream Bio Pharma Inc. (HILS) during Q2 2023. The information is specifically focused on institutions that hold shares of Hillstream BioPharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
1.33MNew |
$451K - $1.44M
|
1.33M
$3.82M
|
|
|
Aug 09, 2023
Q2 2023
|
Warberg Asset Management LLC
Winnetka, IL |
BUY
|
- |
86.6KNew |
$29.4K - $94.4K
|
86.6K
$249K
|
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
18.5K+ 69.47% |
$6.27K - $20.1K
|
45K
$130K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
5.6K+ 47.34% |
$1.9K - $6.1K
|
17.4K
$50.2K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
39+ 125.81% |
$13.3 - $42.5
|
70
$202
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-564- 1.47% |
$192 - $615
|
37.7K
$109K
|